# A022101 (NCT05673148)

> Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: limited metastatic colorectal cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05673148
- Phase: PHASE2
- Status: RECRUITING
- Sponsor: Alliance for Clinical Trials in Oncology
- Conditions: Metastatic Colorectal Adenocarcinoma; Stage IV Colorectal Cancer AJCC v8; Oligometastatic Colorectal Carcinoma
- Interventions: Stereotactic Ablative Radiotherapy; Resection; Microwave Ablation; Chemotherapy; Computed Tomography; Magnetic Resonance Imaging; Positron Emission Tomography
- Enrollment: 146
- Primary outcome: Overall Survival (OS)

## Indexed commentary on A022101 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 4 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=a022101-nct05673148